id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0176-0004,FDA,FDA-2006-N-0176,Supporting Statement for Guidance for Industry - Continuous Marketing Applications: Pilot 2 — Scientific Feedback and Interactions During Development of Fast Track Products Under PDUFA,Supporting & Related Material,Statement (Supporting and Related Material),2007-10-29T04:00:00Z,2007,10,,,2025-06-20T17:28:05Z,,0,0,0900006480450b61
FDA-2006-N-0176-0003,FDA,FDA-2006-N-0176,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Continuous Marketing Applications: Pilot- Scientific Feedback and Interactions
During Development of Fast Track Products Under the Prescription Drug User Fee Act",Notice,Notice of Approval,2007-10-25T04:00:00Z,2007,10,2007-10-25T04:00:00Z,,2025-06-20T17:24:04Z,E7-21056,0,0,0900006480450b60
FDA-2006-N-0176-0002,FDA,FDA-2006-N-0176,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Continuous Marketing Applications: Pilot 2-Scientific Feedback and Interactions During Development of Fast Track Products Under the Prescription Drug User Fee Act,Notice,General Notice,2007-05-21T04:00:00Z,2007,5,2007-05-21T04:00:00Z,2007-06-21T03:59:59Z,2025-06-20T17:18:43Z,E7-9709,0,0,0900006480450b5f
FDA-2006-N-0176-0001,FDA,FDA-2006-N-0176,Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Continuous Marketing Applications: Pilot 2-Scientific Feedback and Interactions During Development of Fast Track Products Under the Prescription Drug User Fee Act,Notice,General Notice,2006-07-24T04:00:00Z,2006,7,2006-07-24T04:00:00Z,2006-09-23T03:59:59Z,2025-06-20T17:11:18Z,E6-11643,0,0,0900006480450b5e